University of Kentucky

University of Kentucky Researchers Unite to Fight COVID-19

3-Apr-2020 8:55 AM EDT, by University of Kentucky

LEXINGTON, Ky. (April 3, 2020)  Researchers and faculty from multiple disciplines across the University of Kentucky are coming together as part of the global effort to treat, understand and eradicate COVID-19.

The COVID-19 Unified Research Experts (CURE) Alliance team, a new workgroup within UK’s College of Medicine, is bringing together UK experts from across the campus to focus on advising COVID-19 patient care and clinical trials based on emerging research and potential treatment options.

College of Medicine Dean Robert DiPaola recently announced the creation of CURE, which the college is funding with additional support from UK’s Vice President for Research Lisa Cassis.

“As we all work together in this unprecedented crisis, the strength and expertise we have in clinical care, research, and instruction across the University of Kentucky is readily apparent,” DiPaola said. “As the world seeks to find preventive and therapeutic means to help with this virus, it is important to maximize and mobilize our collective expertise to help guide what we do here, as drugs are being studied and considered for compassionate use for patients and as studies of repurposed drugs are rapidly being launched and completed.”

The team is made up of a wide variety of UK researchers including experts in virology, infectious disease and epidemiology, pharmacy, lung biology and physiology, respiratory disorders and clinical trials.

“Over the next weeks, we will assess emerging studies to guide the College of Medicine’s clinical enterprise to provide the best COVID-19 patient care available,” said CURE leader Rebecca Dutch, a virologist and chair of UK’s Department of Molecular & Cellular Biochemistry. “Our goal in the long term is to identify the best options for patient participation in ongoing clinical trials, as well as clinical trials we can develop right here at UK.”

Dutch says the team, which is now meeting multiple times a week via Zoom, is also identifying potential COVID-19 research collaborations among UK experts. Several CURE team members have expertise directly related to COVID-19.

For example, alliance experts include Lisa Cassis who has a long-standing publication record studying ACE2, the cellular receptor for the novel coronavirus; Peter Morris, chief for the division of pulmonary, critical care, and sleep medicine, whose research expertise includes acute respiratory distress syndrome (ARDS), a lung condition that is a major complication in severe cases of COVID-19; and Vivek Rangnekar, associate director of UK’s Markey Cancer Center, who has conducted clinical trials in cancer patients with hydroxychloroquine, an anti-malaria drug that the FDA recently approved to treat patients with COVID-19.

Dutch says that this breadth of research expertise will play a key role in current patient treatment, as well as understanding that could lead to new antiviral medications, vaccines, and important treatment developments in the future.

“First and foremost, we’re making smart decisions as a team as far as the best direction for patient health and for the good of the people of Kentucky,” Dutch said.




Filters close

Showing results

110 of 3817
Released: 30-Oct-2020 6:35 PM EDT
UCLA Health infectious disease experts tout critical role mask wearing plays in limiting spread of COVID-19
University of California, Los Angeles (UCLA), Health Sciences

With thousands of new cases logged daily and a vaccine to fight COVID-19 still in development, UCLA Health infectious disease experts are encouraging people to continue to wear masks as the best method of protecting against virus transmission.

Released: 30-Oct-2020 5:35 PM EDT
Surgeon General expects COVID-19 vaccine to be available by year’s end
University of California, Los Angeles (UCLA), Health Sciences

In a wide-ranging talk with UCLA Health physicians, Wednesday, Oct. 28, United States Surgeon General Jerome Adams, MD, MPH, addressed the politicization of the pandemic and the means of containing the spread of COVID-19. He also offered hope that a vaccine for the virus will be available by year’s end.

Released: 30-Oct-2020 4:15 PM EDT
Study shows myocarditis linked to COVID-19 not as common as believed
Louisiana State University Health Sciences Center - New Orleans

A study conducted by Richard Vander Heide, MD, PhD, Professor and Director of Pathology Research at LSU Health New Orleans School of Medicine, and Marc Halushka, MD, PhD, Professor of Pathology at Johns Hopkins University School of Medicine, suggests myocarditis caused by COVID-19 may be a relatively rare occurrence.

access_time Embargo lifts in 2 days
Embargo will expire: 3-Nov-2020 11:00 AM EST Released to reporters: 30-Oct-2020 3:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Nov-2020 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: 247373_web.jpg
Released: 30-Oct-2020 2:30 PM EDT
Researcher develops app to reach Black community with COVID-19 information
University of Cincinnati

A University of Cincinnati cardiologist is partnering with researchers in St. Louis and rural Georgia to develop a smartphone app that will deliver COVID-19 information and education that is targeted toward Black communities.

Newswise: 247467_web.jpg
Released: 30-Oct-2020 1:55 PM EDT
SARS-CoV-2 might attack red marrow and block new erythrocytes formation
Far Eastern Federal University

Specialists from the Department of Fundamental Medicine of Far Eastern Federal University (FEFU) with Russian and Japanese colleagues have probed into mechanisms of COVID-19 inside-the-body distribution linked to erythrocytes damaging. According to researchers, the virus might attack red marrow, thus being detrimental not only for erythrocytes in the bloodstream but also for the process of the formation of the new ones.

Released: 30-Oct-2020 12:40 PM EDT
Government of Canada awards $2.5M to McMaster University to support the COVID-19 border study with McMaster HealthLabs
McMaster University

McMaster University has been awarded $2.5 million from the Government of Canada to support the McMaster HealthLabs (MHL) Canadian International COVID-19 Surveillance Border Study at Toronto Pearson International Airport, being run in partnership with Air Canada and the Greater Toronto Airports Authority (GTAA).

Released: 30-Oct-2020 12:00 PM EDT
5 Big Questions on Health Care and COVID-19
University of Virginia Darden School of Business

The coronavirus pandemic has once again thrust the unusual state of American health care into the spotlight. With a presidential election that could have a dramatic impact on the state of health care for millions on 3 November, Professor Vivian Riefberg considers the state of the industry.

Newswise: Infection by Confection: COVID-19 and the Risk of Trick-or-Treating
Released: 30-Oct-2020 11:05 AM EDT
Infection by Confection: COVID-19 and the Risk of Trick-or-Treating
University of California San Diego Health

Researchers determined that COVID-19 transmission risk via Halloween candies is low, even when they are handled by infected people, but handwashing and disinfecting collected sweets reduces risk even further.

Newswise:Video Embedded third-spike-in-covid-19-cases-plus-the-vaccine-trials-live-expert-panel-for-october-29-3pm-edt
VIDEO
Released: 30-Oct-2020 9:40 AM EDT
TRANSCRIPT AND VIDEO AVAILABLE: "Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29
Newswise

"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT


Showing results

110 of 3817

close
1.12234